Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Dynamic Biotechnology & Genome Invesco ETF (NY: PBE )

58.98 USD -0.72 (-1.21%)
Official Closing Price Updated: 8:00 PM EST, Jan 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,859
Open 59.40
Bid (Size) 57.81 (26)
Ask (Size) 60.00 (25)
Prev. Close 59.70
Today's Range 58.91 - 60.34
52wk Range 58.91 - 84.86
Shares Outstanding 38,900
Dividend Yield 0.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sum Up The Pieces: PBE Could Be Worth $95
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
PBE's Holdings Could Mean 18% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel

Performance

YTD
-17.43%
-17.43%
1 Month
-17.98%
-17.98%
3 Month
-21.41%
-21.41%
6 Month
-21.21%
-21.21%
1 Year
-21.84%
-21.84%

More News

Read More
Could Biotech ETFs Be Due For More Upside?
Tags iShares ARKG Defiance
From ETF Trends
Biotech ETFs Benefit From Moderna Dual Booster Shot News
Tags MRNA booster Invesco
From ETF Trends
Biotech ETFs That Outperformed Last Week
Tags Pharma/Biotech ETFs Market News
From TalkMarkets
PBE's Underlying Holdings Imply 23% Gain Potential
Tags ETFs
From ETF Channel
Could Biotech ETFs Get Another Boost From JNJ News?
Tags delta variant Invesco booster
From ETF Trends
Biotech ETFs Are Already Benefitting from Pfizer Vaccine’s Full Approval
Tags PBE delta variant Invesco
From ETF Trends
Will Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug?
From ETF Trends
Add Up The Pieces: PBE Could Be Worth $89
From ETF Channel
A Comprehensive Guide To Genomic ETFs
Tags Stocks / Equities Market News Pharma/Biotech
From TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.